NextGen Omics Series UK:
04 - 06 November 2020, GMT (UTC+0)

Join over 1400 leaders, experts and researchers at the most scientifically engaging virtual event in Europe. Delivering breakthrough research, technologies and therapeutic applications across Next Generation Sequencing, Clinical Diagnostics, Single Cell Analysis, Genome Editing and Digital PCR

The NextGen Omics Series UK features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell Analysis, Genome Editing and Digital PCR

Live Webinar

FluidFM: a new approach
to CRISPR gene editing

Thursday, Mar 19 2020 | 1:00 PM - 2:00 PM GMT

hosted by Dr. Paul Monnier, Field Application Scientist
& Dr. Maria Milla, Life Sciences Application Scientist

Key Speakers

The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

No data was found

Delegate Rates

Virtual passes are available in Free & Full levels. Click the comparison chart to see what access is provided at each level.

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual experiences.

Young Investigator Best Poster Awards

Honouring outstanding individual performance for a scientific work by PhD students and early career scientists

Free Pre-Event Half-Day Workshop

Join our Diamond Sponsor Takara Bio on 4th November for series of discussions, starting with networking lunch

Virtual Conference Venue

Our fully featured platform offers an immersive conference experience, delivering all the benefits of an in-person event

Digital Networking Opportunities

Connect directly with other registrants of event around the world through direct 1-2-1 chat, video chat and group discussion

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.

Virtual Attendance of the event is available in Free* and Full packages

Feature

Free

Full

Access to 10-15 live presentations and discussions

Access to the online platform

2 Days

7 Days

Access to all on-demand content (70+ presentations)

Ability to download all content

Access to conference documentation

(workbook, poster displays, etc.)

*Free passes are only available to industry R&D or academia.

Live Webinar

Genomic Testing Strategies For Research Through To Clinical Studies: Profiling Of Genomics From NeoGenomics' Perspective

As genomic technologies develop and mature, adoption moves from the research environment into the clinical setting.  Previously, where Sanger and qPCR were the most rational choices to commercialize a diagnostic, NGS has become the biomarker testing methodology of choice.  Additionally, other emerging technologies and platforms like NanoString are finding their way into clinical trials as well as routine diagnostics.  With advances in technology, biomarker testing strategies have also evolved with a trend toward higher order multiplexed technologies as well as cross modality testing from a single sample to understand correlations between DNA, RNA and protein markers.  More data may be over burdensome to analyze, while a focused assay may miss an opportunity for collecting potentially valuable data.  Without a straightforward “rule of thumb” for which genomics technology to use when, thoughtful consultation is required.  This presentation will discuss the various factors and consideration points for choosing a genomic biomarker testing strategy to support biomarker projects.

Presented by James Yen, Senior Scientific Manager, CDx Programs, NeoGenomics

Thursday, 25 June 2020 | 15:30 BST